(4.5 mg, 0.02 mmol) and DPPF (23 mg, 0.04 mmol) in 1,4-dioxane
(1 mL) was then added. The resulting mixture was heated at 70 °C
for 1 h, when GC analysis of the reaction mixture indicated the
complete consumption of 3. The reaction was cooled to room
temperature, and AcOH (1 N, 2 mL) and EtOAc (8 mL) were added
sequentially. The organic layer was dried, concentrated, and
chromatographed (SiO2, hexanes f 15% EtOAc/hexanes) to give
mixture indicated the complete consumption of 3. The reaction was
cooled to room temperature, and methyl iodide (170 mg, 1.2 mmol)
was added. The resulting mixture was stirred at ambient temperature
for 1 h, and GC analysis indicated complete consumption of ethyl
2-phenylcyanoacetate. Hexanes (10 mL) was then added and the
resulting suspension was passed through a frit. The filtrate was
concentrated and column chromatographed (SiO2, hexanes f 10%
EtOAc/hexanes) to give ethyl 2-methyl-2-phenylcyanoacetate as a
colorless oil (179 mg, 88%). 1H NMR (400 MHz, CDCl3): δ 7.52-
7.54 (m, 2 H), 7.34-7.42 (m, 3 H), 4.18-4.27 (m, 2 H), 1.94 (s,
3 H), 1.23 (t, J ) 7.2 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ
167.9, 135.9, 129.2, 128.8, 125.7, 119.5, 63.2, 48.3, 24.9, 13.8.
1
ethyl 2-phenylcyanoacetate as a colorless oil (171 mg, 90%). H
NMR (400 MHz, CDCl3): δ 7.37-7.46 (m, 5H), 4.74 (s, 1H),
4.18-4.24 (m, 2H), 1.24 (t, J ) 7.2 Hz, 3H). 13C NMR (100 MHz,
CDCl3): δ 165.1, 130.1, 129.3, 129.2, 127.9, 115.8, 63.2, 43.7,
13.9.
Ethyl 2-(2-Pyridinyl)cyanoacetate14 (Table 1, entry 14): 3 (113
mg, 1.0 mmol) and 2-bromopyridine (190 mg, 1.2 mmol) were
added sequentially to a suspension of KOt-Bu (280 mg, 2.5 mmol)
in 1,4-dioxane (3 mL), resulting in a white suspension. A prepared
solution of Pd(OAc)2 (4.5 mg, 0.02 mmol) and DPPF (23 mg, 0.04
mmol) in 1,4-dioxane (1 mL) was then added. The resulting mixture
was heated at 70 °C for 1 h, when GC analysis of the reaction
mixture indicated complete consumption of 3. The reaction was
cooled to room temperature and AcOH (1 N, 2 mL) and methylene
chloride (8 mL) were added sequentially. The organic layer was
dried, concentrated, and chromatographed (SiO2, CH2Cl2) to give
ethyl 2-(2-pyridinyl)cyanoacetate as a yellow solid (162 mg, 85%).
1H NMR (400 MHz, CDCl3): δ 14.01 (s, 1H), 7.65 (d, J ) 6.0
Hz, 1H), 7.59 (t, J ) 8.0 Hz, 1H), 7.30 (d, J ) 9.2 Hz, 1 H), 6.67
(t, J ) 6.4 Hz, 1H), 4.24 (q, J ) 7.2 Hz, 2 H), 1.33 (t, J ) 7.6 Hz,
3H). 13C NMR (100 MHz, CDCl3): δ 170.5, 155.6, 139.7, 134.0,
120.4, 119.3, 112.5, 62.6, 60.2, 14.6.
General Procedure for the One-Pot Synthesis of 2-Alkyl-2-
arylcyanoacetates with Aryl and Heteroaryl Bromides: Ethyl
2-Methyl-2-phenylcyanoacetate5b (Table 1, entry 2): To suspen-
sion of KOt-Bu (280 mg, 2.5 mmol) in 1,4-dioxane (3 mL) was
added 3 (113 mg, 1.0 mmol) and bromobenzene (188 mg, 1.2
mmol) sequentially, resulting in a white suspension. A prepared
solution of Pd(OAc)2 (4.5 mg, 0.02 mmol) and DPPF (23 mg, 0.04
mmol) in 1,4-dioxane (1 mL) was then added. The resulting mixture
was heated at 70 °C for 1 h, when GC analysis of the reaction
2-Allyl-2-(2-pyridinyl)cyanoacetate (Table 1, entry 15): 3 (113
mg, 1.0 mmol) and 2-bromopyridine (190 mg, 1.2 mmol) were
added sequentially to a suspension of KOt-Bu (280 mg, 2.5 mmol)
in 1,4-dioxane (3 mL), resulting in a white suspension. A prepared
solution of Pd(OAc)2 (4.5 mg, 0.02 mmol) and DPPF (23 mg, 0.04
mmol) in 1,4-dioxane (1 mL) was then added. The resulting mixture
was heated at 70 °C for 1 h, when GC analysis of the reaction
mixture indicated the complete consumption of 3. The reaction was
cooled to room temperature, and allyl bromide (145 mg, 1.2 mmol)
was added. The resulting mixture was stirred at ambient temperature
for 1 h, and HPLC analysis indicated complete consumption of
ethyl 2-(2-pyridinyl)cyanoacetate. Aqueous AcOH (1 N, 2 mL) and
methylene chloride (8 mL) were added sequentially. The filtrate
was concentrated and column chromatographed (SiO2, 10% f 50%
EtOAc/hexanes) to give ethyl 2-allyl-2-(2-pyridinyl)cyanoacetate
as a pale yellow oil (191 mg, 83%). 1H NMR (400 MHz, CDCl3):
8.62 (d, J ) 4.8 Hz, 1 H), 7.78 (t, J ) 7.6 Hz, 1 H), 7.62 (d, J )
8.4 Hz, 1 H), 7.30-7.33 (m, 1 H), 5.73-5.83 (m, 1 H), 5.19-5.26
(m, 2 H), 4.25-4.30 (m, 2 H), 3.17 (dd, J ) 7.2, 14.0 Hz, 1 H),
3.04 (dd, J ) 7.2, 14.0 Hz, 1 H), 1.25 (t, J ) 7.2 Hz, 3 H). 13C
NMR (100 MHz, CDCl3): δ 164.7, 152.2, 148.3, 136.0, 129.3,
122.1, 120.1, 119.6, 116.4, 61.8, 54.6, 39.3, 12.4.
Acknowledgment. X.W. thanks Drs. Jinkun Huang and
Robert R. Milburn for helpful discussions and suggestions and
Drs. Tiffany Correll and Kevin Turney for assistance on HRMS
analysis and IR measurement.
(12) (a) Shen, Q.; Shekhar, S.; Stambuli, J. P.; Hartwig, J. F. Angew.
Chem., Int. Ed. 2005, 44, 1371-1375. (b) Widenhoefer, R. A.; Buchwald,
S. L. Organometallics 1996, 15, 3534-3542. (c) Frederic, P.; Patt, J.;
Hartwig, J. F. Organometallics 1995, 14, 3030-3039.
(13) Abdelaziz, A. S.; Dedenus, C. R. J. Chem. Soc., Perkin. Trans. 1
1993, 293-298.
(14) Miyashita, A.; Sato, Y.; Watanabe, S.; Tanji, K.-I.; Higashino, T.
Chem. Pharm. Bull. 1995, 43, 174-6 Sakamoto, T.; Kato, E.; Kondo, Y.;
Yamanaka, H. Chem. Pharm. Bull. 1988, 36, 1664-1668.
Supporting Information Available: Synthetic methods and
spectral assignments and copies of 1H NMR and 13C NMR for all
products. This material is available free of charge via the Internet
JO7024338
J. Org. Chem, Vol. 73, No. 4, 2008 1645